Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  De Ferrari, Aldo ^a   Gentille, Cesar ^a   Davalos, Long ^a   Huayanay, Leandro ^a   Malaga, German ^a,b  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENERAL HOSPITAL; HUMAN; INSTITUTIONAL ETHICS; MALE; MEDICAL EDUCATION; MEDICAL ETHICS; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; PERU; PHARMACY; PHYSICIAN ATTITUDE; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; RESIDENT; SOCIAL ATTITUDE; SOCIAL INTERACTION; CLINICAL PRACTICE; CONFLICT OF INTEREST; CROSS-SECTIONAL STUDY; DRUG INDUSTRY; ECONOMICS; ETHICS; GIFT GIVING; HEALTH PERSONNEL ATTITUDE; MARKETING; MIDDLE AGED; PHYSICIAN; PUBLIC HOSPITAL; PUBLIC RELATIONS; QUESTIONNAIRE;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CONFLICT OF INTEREST; CROSS-SECTIONAL STUDIES; DRUG INDUSTRY; ETHICS, MEDICAL; FEMALE; GIFT GIVING; HOSPITALS, GENERAL; HOSPITALS, PUBLIC; HUMANS; INTERPROFESSIONAL RELATIONS; MALE; MARKETING; MIDDLE AGED; PERU; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; QUESTIONNAIRES;

EID: 84903624807     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100114     Document Type: Article

References (27)

1. Komesaroff P (2010) Ethical issues associated with gifts provided by the pharmaceutical industry. Intern Med J 40: 321-322.
2. Norris P, Herxheimer A, Lexchin J, Mansfield P (2004) Drug Promotion - What We Know, What We Have Yet to Learn - Reviews of Materials in the WHO/HAI Database on Drug Promotion - EDM Research Series No. 032. Available: http://apps.who.int/medicinedocs/en/d/Js8109e/2.html. Accessed 1 October 2012.
3. National Research Council (2009) Conflict of interest in medical research, education, and practice [consensus report]. In: Lo B, Field MJ, editors. Washington, DC: National Academies Press. Available: http://www.iom.edu/Reports/2009/Conflict-of-Interest-in-Medical-Research- Education-and-Practice.aspx. Accessed 14 October 2012.
4. Gagnon M, Lexchin J (2008) The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States. PLoS Medicine 5(1), e1. doi:10.1371.
5. Katz D, Caplan AL, Merz JF (2003) All gifts large and small: Toward an understanding of the ethics of pharmaceutical industry gift-giving. Am J Bioeth 3: 39-46. doi:10.1080/15265161.2010.519226.
6. Wazana A (2000) Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA 283: 373-380. doi: 10.1001/jama.283.3.373.
7. Dana J, Loewenstein G (2003) A social science perspective on gifts to physicians from industry. JAMA 290: 252-255.
8. Korenstein D, Keyhani S, Ross J (2010) Physician Attitudes Toward Industry. Arch Surg 145: 570-577.
9. Adair R, Holmgren L (2005) Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med 118: 881-884. doi:10.1016/j.amjmed.2005. 02.031.
10. Zipkin D, Steinman M (2005) Interaction between pharmaceutical representatives and doctors in training: A thematic review. J Gen Intern Med 20: 777-786.
11. Galán Herrera S, Delgado M, Altisent R (2004) Análisis de la relación entre el médico de atención primaria y la industria farmacéutica. Aten Primaria 34: 231-247.
12. Chen J., Vargas-Bustamante A (2013) Treatment compliance under physicianindustry relationship: a framework of health-care coordination in the US. Int. J Qual Health Care, 1-8.
13. Beaton D, Bombardier C, Guillermin F, Bosi Ferraz M (2000) Guidelines for the Process of Cross-Cultural Adaptation of Self-Report Measures. SPINE 25: 3186-3191.
14. Lieb K, Brandtonies S (2010) A survey of german physicians in private practice about contacts with pharmaceutical sales representatives. Dtsch Arztebl Int; 107 (22): 392-8.
15. Birkhahn R, Blomkalns A, Klausner H, et al (2008) Academic emergency faculty and industry relationships. Academic Emergency Medicine 15:819-824
16. McNeill PM, Kerridge IH, Henry DA, Stokes B, Hill SR, et al. (2006) Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia. Intern Med J 36 (9): 571-578.
17. Campbell E, Gruen R, Mountford J, Miller L, Cleary P, Blumenthal D (2007) A National Survey of Physician-Industry Relationships. N Engl J Med 356: 1742-1750.
18. Saito S, Mukohara K, Bito S (2010) Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey. Plos One 5 (8):e12193
19. Alssageer M, Kowalski R (2012) A survey of pharmaceutical company representative interactions with doctors in Libya. Lybian J Med, 7: 18556.
20. Valenzuela-Rodriguez G (2010) Apreciación del representante médico por el médico internista. Rev Soc Peru Med Interna 23: 150-156.
21. Lexchin J (1993) Interactions between physicians and the pharmaceutical industry: What does the literature say? CMAJ 149: 1401-1407.
22. Sergeant M, Hodgetts P, Godwin M, Walker D, McHenry P (1996) Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. CMAJ 155: 1243-1259.
23. Appelbaum P (2010) Contact with pharmaceutical representatives: where does prudence lead? Am J Bioeth 10: 11-13.
24. Chew L, O'Young T, Hazlet T, Bradley K, Maynard C, Lessler D (2000) A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med 15: 478-483.
25. Warrier R, Monaghan M, Maio A, Huggett K, Rich E (2010) Effect of drug sample availability on physician prescribing behavior: a systematic review. Clin Rev Opin 2: 41-8.
26. Kleier J (2012) The high cost of free drug samples. Urol Nurs 32: 8-9,51.
27. Mansfield P (2009) Techniques that influence the use of medicines. In: Mintzes B, Mangin D. eds WHO manual on understanding and responding to drug promotion. WHO [In Press].